Generics in Canada

Find Industry reports, Company profiles
ReportLinker and Market Statistics

>> Get this Report Now by email!

Generics in Canada
Published on September 2010

Report Summary

The Generics in Canada industry profile is an essential resource for top-level data and analysis covering the Generics industry. It
includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape,
leading companies and demographic information.

Scope

* Contains an executive summary and data on value, volume and/or segmentation

* Provides textual analysis of Generics in Canada's recent performance and future prospects

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes a five-year forecast of Generics in Canada

* The leading companies are profiled with supporting key financial metrics

* Supported by the key macroeconomic and demographic data affecting the market

Highlights

* Detailed information is included on market size, measured by value and/or volume

* Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

For the purposes of this Profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have
now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered
by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The
market value is evaluated at ex-factory prices. Market volume is quantified here as the percentage of the total ethical pharmaceutical

Generics in Canada Page 1/5


market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not
an absolute measure of market volume. All currency conversions were calculated at constant average annual 2009 exchange rates.

For the purposes of this report, the Americas consists of North America and South America.

North America consists of Canada, Mexico, and the United States.

South America comprises Argentina, Brazil, Chile, Colombia, and Venezuela.

Table of Content

TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET VOLUME 11
MARKET SEGMENTATION II 12
FIVE FORCES ANALYSIS 13
Summary 13
Buyer power 15
Supplier power 16
New entrants 17
Substitutes 19
Rivalry 20
LEADING COMPANIES 21
Apotex, Inc. 21
Mylan Laboratories Inc. 23
Teva Pharmaceutical Industries 26
MARKET FORECASTS 30
Market value forecast 30
Market volume forecast 31
MACROECONOMIC INDICATORS 32
APPENDIX 34
Methodology 34
Industry associations 35
Related Datamonitor research 35
Disclaimer 36
ABOUT DATAMONITOR 37
Premium Reports 37
Summary Reports 37
Datamonitor consulting 37

LIST OF TABLES
Table 1: Canada generics market value: $ billion, 2005'09 10



Table 2: Canada generics market volume: volume penetration, 2005'09 11
Table 3: Canada generics market segmentation II: % share, by value, 2009 12
Table 4: Apotex, Inc.: key facts 21
Table 5: Mylan Laboratories Inc.: key facts 23
Table 6: Mylan Laboratories Inc.: key financials ($) 24
Table 7: Mylan Laboratories Inc.: key financial ratios 24
Table 8: Teva Pharmaceutical Industries: key facts 26
Table 9: Teva Pharmaceutical Industries: key financials ($) 28
Table 10: Teva Pharmaceutical Industries: key financial ratios 28
Table 11: Canada generics market value forecast: $ billion, 2009'14 30
Table 12: Canada generics market volume forecast: volume penetration, 2009'14 31
Table 13: Canada size of population (million), 2005'09 32
Table 14: Canada gdp (constant 2000 prices, $ billion), 2005'09 32
Table 15: Canada gdp (current prices, $ billion), 2005'09 32
Table 16: Canada inflation, 2005'09 33
Table 17: Canada consumer price index (absolute), 2005'09 33
Table 18: Canada exchange rate, 2005'09 33

LIST OF FIGURES
Figure 1: Canada generics market value: $ billion, 2005'09 10
Figure 2: Canada generics market volume: volume penetration, 2005'09 11
Figure 3: Canada generics market segmentation II: % share, by value, 2009 12
Figure 4: Forces driving competition in the generics market in Canada, 2009 13
Figure 5: Drivers of buyer power in the generics market in Canada, 2009 15
Figure 6: Drivers of supplier power in the generics market in Canada, 2009 16
Figure 7: Factors influencing the likelihood of new entrants in the generics market in Canada, 2009 17
Figure 8: Factors influencing the threat of substitutes in the generics market in Canada, 2009 19
Figure 9: Drivers of degree of rivalry in the generics market in Canada, 2009 20
Figure 10: Mylan Laboratories Inc.: revenues & profitability 25
Figure 11: Mylan Laboratories Inc.: assets & liabilities 25
Figure 12: Teva Pharmaceutical Industries: revenues & profitability 29
Figure 13: Teva Pharmaceutical Industries: assets & liabilities 29
Figure 14: Canada generics market value forecast: $ billion, 2009'14 30
Figure 15: Canada generics market volume forecast: volume penetration, 2009'14 31



Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.

Generics in Canada

Product Formats
Please select the product formats and the quantity you require.

Digital Copy--USD 250.00 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________



Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


Generics in Canada

More Related Content

What's hot

Similar to Generics in Canada

More from ReportLinker.com

Recently uploaded

Generics in Canada